Scarica l'app Stockscreener
3.46
12.34%
0.38
Pre-mercato:
3.46
Precedente Chiudi:
$3.08
Aprire:
$3.36
Volume 24 ore:
810.40K
Relative Volume:
0.99
Capitalizzazione di mercato:
$224.46M
Reddito:
$212.69M
Utile/perdita netta:
$-59.00M
Rapporto P/E:
-3.7057
EPS:
-0.9337
Flusso di cassa netto:
$-29.49M
1 W Prestazione:
+24.46%
1M Prestazione:
+94.38%
6M Prestazione:
+16.11%
1 anno Prestazione:
-40.96%
Intervallo 1D:
$3.285
$3.525
Intervallo di 1 settimana:
$2.73
$3.525
Portata 52W:
$1.17
$7.78
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Nome
Treace Medical Concepts Inc
Settore
Industria
Telefono
(904) 373-5940
Indirizzo
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
3.46 | 199.81M | 212.69M | -59.00M | -29.49M | -0.9337 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-11-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-02-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-12-31 | Iniziato | Lake Street | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Neutral |
| 2024-05-16 | Downgrade | UBS | Buy → Neutral |
| 2024-05-08 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Downgrade | Stifel | Buy → Hold |
| 2024-05-08 | Downgrade | Truist | Buy → Hold |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2023-04-11 | Iniziato | Stephens | Equal-Weight |
| 2022-05-12 | Iniziato | BTIG Research | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Iniziato | JP Morgan | Overweight |
| 2021-05-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Iniziato | SVB Leerink | Outperform |
| 2021-05-18 | Iniziato | Stifel | Buy |
Mostra tutto
Treace Medical Concepts Inc Borsa (TMCI) Ultime notizie
Treace Medical (NASDAQ:TMCI) CEO John Treace acquires $340,588 in shares - Investing.com
Treace Medical Concepts Insider Bought Shares Worth $340,589, According to a Recent SEC Filing - marketscreener.com
Treace Medical Concepts (TMCI) CEO buys 115,520 shares of stock - Stock Titan
TMCI Technical Analysis | Trend, Signals & Chart Patterns | TREACE MEDICAL CONCEPTS INC (NASDAQ:TMCI) - ChartMill
William Blair Investment Management LLC Sells 2,488,883 Shares of Treace Medical Concepts, Inc. $TMCI - MarketBeat
Treace Medical Concepts, Inc. 8-K SEC Filing Details and Company Information (May 19, 2026) - Minichart
Treace Medical Shareholders Back Directors, Pay and Auditor - TipRanks
Treace Medical Concepts shareholders elect directors and approve key proposals - Investing.com Australia
Treace Medical Concepts shareholders elect directors and approve key proposals By Investing.com - Investing.com South Africa
Treace Medical (TMCI) shareholders elect directors and ratify auditor at 2026 meeting - Stock Titan
TMCI SEC FilingsTreace Medical Concepts, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Director at Treace Medical (TMCI) receives 30,000 restricted stock units - Stock Titan
Treace Medical (TMCI) awards 30,000 RSUs to company director - Stock Titan
Treace Medical (TMCI) director receives 30,000 RSU equity award and updates holdings - Stock Titan
Armistice Capital (TMCI) discloses 6.36M shares, 9.85% stake - Stock Titan
Treace Medical Concepts Q1 earnings call highlights - MSN
Treace Medical Concepts Insider Bought Shares Worth $375,505, According to a Recent SEC Filing - Moomoo
Treace Medical Concepts CEO John Treace buys $375,505 in shares By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John Treace buys $375,505 in shares - Investing.com
TMCI (TMCI) CEO John Treace purchases over 150,000 company shares in open market - Stock Titan
Bank of America (TMCI) reports 3.53M shares, 5.5% ownership - Stock Titan
Treace Medical Concepts, Inc. Shareholders Are Encouraged - GlobeNewswire
Treace Medical Concepts (TMCI) Price Target Decreased by 35.65% to 5.58 - MSN
Treace Medical Concepts Q1 Earnings Call Highlights - MarketBeat
Treace Medical Concepts (TMCI) Q4 Loss Narrowing To US$0.15 EPS Tests Bearish Narratives - Sahm
Treace Medical Concepts: Q1 Earnings Snapshot - theheraldreview.com
Treace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings Results - MarketBeat
Treace Hikes on Q1 Numbers - Baystreet.ca
Treace Medical Concepts, Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Treace Medical Concepts beats Q1 2026 forecasts By Investing.com - Investing.com Australia
Earnings call transcript: Treace Medical Concepts beats Q1 2026 forecasts - Investing.com
Treace Medical Concepts Backs 2026 Rev $202M-$212M >TMCI - Moomoo
Treace Medical Concepts Inc (NASDAQ:TMCI) Jumps 9% Pre-Market After Q1 Earnings Beat Despite Revenue Decline - ChartMill
Treace Medical Concepts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Treace Medical Concepts Reports First Quarter 2026 Financial Results - The Manila Times
Treace Medical Concepts reports Q1 2026 revenue $47.2M, net loss $18.0M, reaffirming 2026 guidance - TradingView
[10-Q] TREACE MEDICAL CONCEPTS, INC. Quarterly Earnings Report - Stock Titan
Bunion surgery device maker posts 10% sales drop, keeps 2026 target - Stock Titan
Treace Medical (NASDAQ: TMCI) Q1 2026 sales fall 10% as losses widen - Stock Titan
Treace Medical Concepts, Inc. Reaffirms Earnings Guidance for the Full-Year 2026 - marketscreener.com
Treace Medical Concepts, Inc. (TMCI) Investor Outlook: Exploring A Potential 121% Upside - DirectorsTalk Interviews
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
How The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst Expectations - Yahoo Finance
Treace Medical Concepts (TMCI) to Release Earnings on Friday - MarketBeat
Treace Medical Concepts (TMCI) price target increased by 12.28% to 4.08 - MSN
Treace Medical Concepts Inc Azioni (TMCI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):